Dr. Agarwal’s Health Care Q3 FY26: Board meet Feb 3

What the company has announced

Dr. Agarwal’s Health Care Limited has scheduled a meeting of its Board of Directors for Tuesday, February 3, 2026. The board will consider and approve the company’s unaudited financial results, both standalone and consolidated. These results are for the quarter and nine months ended December 31, 2025, described by the company as Q3 2026 (Q3 FY26). The intimation also sets up the next step in the reporting cycle: an earnings or analyst conference call the following day. The disclosures are presented as a formal board meeting intimation and related investor communication.

Board meeting agenda and reporting period

The stated agenda for February 3, 2026 is to review and approve unaudited financial results (standalone and consolidated). The reporting period covered is the quarter ended December 31, 2025, along with the nine months ended December 31, 2025. This matters because the nine-month numbers provide cumulative performance through the first three quarters of the financial year, while the quarterly results show the most recent run-rate. The company has not included any financial figures in the announcement itself. It is a timing and process update focused on when the board will consider the results.

Earnings and analyst call on February 4

The company has also scheduled an Earnings/Analyst Conference Call for Wednesday, February 4, 2026. The call is intended to discuss the financial results once they are approved and announced. As per the disclosure, the call will start at 11:30 A.M. IST and is expected to conclude by 12:30 P.M. IST. The company has indicated that further details for the call will be available on its website. This sequence is consistent with typical listed-company practice, where results approval is followed by a structured interaction with analysts and investors.

Management participants named for the call

Dr. Agarwal’s Health Care has identified the company representatives who will participate in the conference call. The participants listed are Dr. Adil Agarwal, Whole-time Director and Chief Executive Officer, Mr. Yashwanth Venkat, Chief Financial Officer, and Ms. Aashna Dharia, Head, Investor Relations. Naming the executives upfront clarifies who will address questions on performance, operations, and financial statements during the interaction. It also signals that both the business and finance leadership will be present.

Trading window closure under insider trading code

The disclosure states that, in line with the company’s Insider Trading Code, the trading window will remain closed until 48 hours after the announcement of the financial results. Such windows typically apply to designated persons and are intended to reduce the risk of trading on unpublished price sensitive information. The timeline provided links the window reopening to the results announcement, not merely the board meeting end time. Investors tracking compliance updates often watch for this line because it indicates the results release is imminent around the board meeting date.

Dial-in details shared for India participants

For the February 4 call, dial-in information has been provided for India. The numbers listed are +91 22 6280 1308 and +91 22 7115 8161. The disclosure also references international toll-free numbers, though only the heading is visible in the provided text. Investors who plan to join typically use the published dial-in details and any registration links referenced by the company. The company has also said the relevant information will be available on its website.

Key dates and call timing at a glance

Recent pattern of board meeting intimations

The material also includes a list of earlier board meeting dates associated with periodic results approvals for Dr. Agarwal’s Health Care Limited. These include October 30, 2025 (unaudited results for the quarter and half-year ended September 30, 2025), August 12, 2025 (unaudited results for the quarter ended June 30, 2025), and May 28, 2025 (audited results for the quarter and year ended March 31, 2025). A February 14, 2025 entry is also referenced as a quarterly results meeting date. This trail helps investors understand the cadence of results-related disclosures and the company’s reporting rhythm.

Market impact and what investors can realistically infer

The announcement is procedural, so it does not by itself change the company’s reported financial position. Its immediate relevance is that it sets a clear timetable for when the Q3 FY26 unaudited results will be considered and when management will discuss them. The trading-window note is also a practical marker for market participants tracking governance and compliance processes. Because no performance numbers, outlook statements, or operational metrics are included in the text provided, there is no basis here to quantify impact on earnings, margins, or valuation. Any market reaction would typically depend on the results once published and on the discussion during the call.

Why the schedule matters

For analysts and institutional investors, the combination of a board approval date and a scheduled conference call provides a structured window to update models and ask follow-up questions. It also improves visibility on when the nine-month cumulative performance through December 31, 2025 will be available. The company’s choice to specify participants and call timing reduces uncertainty for investors who want to engage soon after the results. Separately, the continuing use of trading-window closures linked to results announcements reflects a standard compliance framework for listed companies.

Conclusion

Dr. Agarwal’s Health Care Limited will take up its unaudited standalone and consolidated Q3 FY26 results at a board meeting on February 3, 2026, for the quarter and nine months ended December 31, 2025. An earnings and analyst call is scheduled for February 4, 2026 from 11:30 A.M. to 12:30 P.M. IST, with company leadership including the CEO, CFO, and Head of Investor Relations. The company has also stated that the trading window will remain closed until 48 hours after the results are announced, and that additional call details will be available on its website.